Skip to main content
. 2021 Jan 26;51(2):193–196. doi: 10.1016/j.neucli.2021.01.003

Table 2.

Details of symptoms (sensory, motor and autonomic) reported by the patients in the whole population and according to the presence (FESC <60 μS) or absence of sudomotor dysfunction (FESC ≥60 μS).

Symptoms Whole population (n = 50) FESC < 60 µS (n = 13) FESC ≥ 60 µS (n = 37) p
Sensory symptoms
Pins and needles 19 (38) 8 (61.5) 11 (29.7) 0.04
Numbness and less ability to feel pain or changes in temperature 17 (34) 4 (30.7) 13 (35.1) 0.77
Burning or sharp pain 17 (34) 11 (84.6) 6 (16.2) <0.0001
Feeling pain from something that should not be painful at all, such as a very light touch 18 (36) 9 (69.2) 9 (24.3) 0.0037
Loss of balance or coordination caused by less ability to tell the position of the limb 1 (2) 1 (7.7) 0 (0) 0.08
Motor symptoms
Twitching and muscle cramps 22 (44) 10 (76.9) 12 (32.4) 0.005
Muscle weakness or paralysis affecting one or more muscles 7 (14) 6 (46.2) 1 (2.7) 0.0001
Thinning (wasting) of muscles 1 (2) 1 (7.7) 0 (0) 0.08
Foot drop, particularly noticeable when walking 0 (0) 0 (0) 0 (0)
Autonomic symptoms
Constipation or diarrhea 5 (10) 2 (15.4) 3 (8.1) 0.45
Feeling sick, bloating, or belching 14 (28) 5 (38.5) 9 (24.3) 0.32
Low blood pressure, which can make you feel faint or dizzy when you stand up 11 (22) 5 (38.5) 6 (16.2) 0.09
Rapid heartbeat 15 (30) 10 (76.9) 5 (13.5) <0.0001
Excessive sweating or a lack of sweating 12 (24) 2 (15.4) 10 (27.1) 0.39
Problems with sexual function, such as erectile dysfunction in men 4 (8) 1 (7.7) 3 (8.1) 0.96
Difficulty emptying your bladder of urine, or loss of bowel control 0 (0) 0 (0) 0 (0)